Your browser doesn't support javascript.
loading
Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer.
Ponnusamy, Suriyan; Coss, Christopher C; Thiyagarajan, Thirumagal; Watts, Kate; Hwang, Dong-Jin; He, Yali; Selth, Luke A; McEwan, Iain J; Duke, Charles B; Pagadala, Jayaprakash; Singh, Geetika; Wake, Robert W; Ledbetter, Christopher; Tilley, Wayne D; Moldoveanu, Tudor; Dalton, James T; Miller, Duane D; Narayanan, Ramesh.
Afiliación
  • Ponnusamy S; Department of Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • Coss CC; GTx, Inc., Memphis, Tennessee.
  • Thiyagarajan T; Department of Medicine, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • Watts K; School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
  • Hwang DJ; Department of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • He Y; Department of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • Selth LA; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia.
  • McEwan IJ; Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia.
  • Duke CB; School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom.
  • Pagadala J; Department of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • Singh G; Department of Pharmaceutical Sciences, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • Wake RW; St. Jude Children's Hospital and Research Center, Memphis, Tennessee.
  • Ledbetter C; Department of Urology, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • Tilley WD; Department of Urology, The University of Tennessee Health Science Center, Memphis, Tennessee.
  • Moldoveanu T; Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia.
  • Dalton JT; Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia.
  • Miller DD; St. Jude Children's Hospital and Research Center, Memphis, Tennessee.
  • Narayanan R; GTx, Inc., Memphis, Tennessee.
Cancer Res ; 77(22): 6282-6298, 2017 11 15.
Article en En | MEDLINE | ID: mdl-28978635
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores Androgénicos / Regulación Neoplásica de la Expresión Génica / Antagonistas de Receptores Androgénicos / Neoplasias de la Próstata Resistentes a la Castración Límite: Animals / Humans / Male Idioma: En Revista: Cancer Res Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores Androgénicos / Regulación Neoplásica de la Expresión Génica / Antagonistas de Receptores Androgénicos / Neoplasias de la Próstata Resistentes a la Castración Límite: Animals / Humans / Male Idioma: En Revista: Cancer Res Año: 2017 Tipo del documento: Article